HCO | Jotup

Now Available: Veeva Compass Suite of Commercial Data Products

Retrieved on:

Tuesday, January 30, 2024

Intelligence, Forecasting, Injection, HCO, Prescription, Veeva Systems, HCP, Surveying

PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of the full Veeva Compass Suite of commercial data products for a more complete view into patient populations and HCP-level insight. Veeva Compass Prescriber and Veeva Compass National are the first to deliver projections for both retail prescriptions and complex procedures, including in-office administered therapies, injections, and infusions. Veeva Compass Suite also includes Compass Patient, granular, longitudinal patient data spanning prescriptions, procedures, and diagnoses. Veeva Compass products are licensed by the brand and give brands unlimited data access, including historical data.

Key Points:

Complete suite of modern patient, prescriber, and national data products for today's complex therapies
PLEASANTON, Calif., Jan. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of the full Veeva Compass Suite of commercial data products for a more complete view into patient populations and HCP-level insight.
Veeva Compass Suite also includes Compass Patient , granular, longitudinal patient data spanning prescriptions, procedures, and diagnoses.
Veeva Compass products are licensed by the brand and give brands unlimited data access , including historical data.
"The availability of the full Veeva Compass Suite of data products is a major milestone for the industry and for Veeva," said Peter Stark, executive vice president and general manager, Veeva Compass.

Asthma & COPD Care Leader Health Care Originals Welcomes Former BCBS CMO Dr. Jennifer Chambers as Chief Medical Officer

Retrieved on:

Thursday, November 2, 2023

Health Care Originals (HCO), the leading chronic respiratory disease management platform, welcomes Dr. Jennifer Chambers, MD, MBA, FACP as Chief Medical Officer.

Key Points:

Health Care Originals (HCO), the leading chronic respiratory disease management platform, welcomes Dr. Jennifer Chambers, MD, MBA, FACP as Chief Medical Officer.
The Health Care Originals team, led by Chief Executive Officer Sharon Samjitsingh, is thrilled to welcome Dr.
"We are honored to have Dr. Jennifer Chambers join us," said Sharon Samjitsingh, Chief Executive Officer.
Health Care Originals’ Nightingale program for respiratory care is revolutionizing the management of asthma and COPD.

Health Care Originals Acquires Dawn Health’s Virtual Care Platform, Paving the Way for Insurance-Covered Access to Respiratory Care Nationwide

Retrieved on:

Tuesday, October 10, 2023

Health, Technology, Health Technology, Other Health, Software, General Health, Patient, HCO, Asthma, Acquisition, Insurance, Person-centered therapy, Sleep, Nursing, Management, Common nightingale

Health Care Originals (HCO), a leading pulmonary care innovator, has announced the strategic acquisition of Dawn Health’s virtual care platform.

Key Points:

Health Care Originals (HCO), a leading pulmonary care innovator, has announced the strategic acquisition of Dawn Health’s virtual care platform.
Founded with the mission to democratize high-quality sleep care, Dawn Health has spent years growing its footprint with leading health plans and serving thousands of patients.
"Dawn Health's clinical infrastructure and national presence create a symbiotic environment for HCO to expand its healthcare solutions on a national scale," said Rahul Shivkumar, former CEO of Dawn Health.
Dawn Health, known for its sleep care innovations, will be seamlessly integrated into HCO's existing platforms to optimize respiratory therapy patient outcomes.

Healthcare Analytics Company PurpleLab™ Launches Next-Gen Solution for Medical Claims Data Exploration

Retrieved on:

Tuesday, August 29, 2023

Health, Health Technology, Other Health, Clinical Trials, General Health, Biotechnology, HCO, CLEAR, Organization, Advertising, Comprehensive layout, SDOH, Table, Exploration, Mining, Pharmaceutical industry

PurpleLab™ , a healthcare analytics company that holds one of the largest claims databases in the US, announced today the launch of a new product, Comprehensive Layout for Exploration, Analysis, & Research (CLEAR).

Key Points:

PurpleLab™ , a healthcare analytics company that holds one of the largest claims databases in the US, announced today the launch of a new product, Comprehensive Layout for Exploration, Analysis, & Research (CLEAR).
With CLEAR, the company seeks to enhance its claims data warehouse with valuable clinically approved and operationally relevant methodologies, facilitating analysis and reducing the amount of data engineering needed to generate insights from claims data.
One of the most costly and time-consuming tasks healthcare organizations and life sciences professionals face today is finding timely and valuable insights while mining through vast amounts of medical and prescription drug (Rx) claims data.
This often leads to outsourcing these analyses to teams of data engineers and data scientists.

Respiratory Care Innovator Welcomes Digital Health Growth Leader, Cameron Jacox, as Key Strategic Advisor: Health Care Originals Preparing for New Phase of Rapid Growth in the Respiratory Care Patient Revolution

Retrieved on:

Thursday, July 27, 2023

Health Care Originals, the leading chronic respiratory disease management platform, is delighted to announce the appointment of Cameron Jacox as Strategic Growth Advisor.

Key Points:

Health Care Originals, the leading chronic respiratory disease management platform, is delighted to announce the appointment of Cameron Jacox as Strategic Growth Advisor.
The team, led by Chief Executive Officer Sharon Samjitsingh, will leverage his expertise at scaling digital health startups and driving rapid growth.
Health Care Originals provides solutions that empower individuals to understand their bodies by developing unique digital biomarkers using its proprietary wearable.
HCO’s newest solution, Nightingale Digital Health, is at the forefront of virtual respiratory care, revolutionizing how individuals manage asthma and COPD.

Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption

Retrieved on:

Wednesday, July 26, 2023

KOL, Lundbeck, Veeva Systems, HCO, MSL, Patient, NYSE, Library and Information Science Abstracts, Pharmaceutical industry, Medical device

PLEASANTON, Calif., July 26, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed findings of field medical's impact on clinical practice in the Veeva Pulse Field Trends Report. Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption. This result across the healthcare organization (HCO) within the first six months post-launch expands reach to more patients that could benefit from new medicines and therapies.

Key Points:

Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption.
Scientific engagement with KOLs has a lasting impact on new treatment adoption and most KOLs are asking for more interactions with MSLs.
Veeva Pulse analysis shows pre-launch field medical educational engagement with KOLs has a measurable benefit on new treatment adoption:
MSL engagement with KOLs before launch drives 1.5 times greater treatment adoption.
"This deeper understanding of scientific engagement and treatment adoption shows the impact of field medical on launch success and most KOLs have greater potential to work with more field medical representatives to get the right medicine to the right patients faster," said Dan Rizzo, global head of Veeva business consulting.

Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption

Retrieved on:

Wednesday, July 26, 2023

KOL, Lundbeck, HCO, MSL, Patient, NYSE, Library and Information Science Abstracts, Pharmaceutical industry, Medical device, Veeva Systems

BARCELONA, Spain, July 26, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed findings of field medical's impact on clinical practice in the Veeva Pulse Field Trends Report. Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption. This result across the healthcare organization (HCO) within the first six months post-launch expands reach to more patients that could benefit from new medicines and therapies.

Key Points:

Analysis shows that disease state education by medical science liaisons (MSLs) with key opinion leaders (KOLs) before launch leads to 1.5 times greater treatment adoption.
Scientific engagement with KOLs has a lasting impact on new treatment adoption and most KOLs are asking for more interactions with MSLs.
Veeva Pulse analysis shows pre-launch field medical educational engagement with KOLs has a measurable benefit on new treatment adoption:
MSL engagement with KOLs before launch drives 1.5 times greater treatment adoption.
"This deeper understanding of scientific engagement and treatment adoption shows the impact of field medical on launch success and most KOLs have greater potential to work with more field medical representatives to get the right medicine to the right patients faster," said Aaron Bean, vice president of Veeva commercial business consulting, Europe.

Reltio Introduces Offerings to Accelerate Time-To-Value and Speed Data-Driven Innovation for Life Sciences and Healthcare Markets

Retrieved on:

Thursday, February 23, 2023

Today, Reltio introduced two offerings, the Reltio for Life Sciences and Reltio for Healthcare velocity packs.

Key Points:

Today, Reltio introduced two offerings, the Reltio for Life Sciences and Reltio for Healthcare velocity packs.
The predefined universal data models for core data domains, aligned with leading industry standards for interoperability, help life sciences companies and healthcare organizations collect, unify, and activate trusted, high-quality data in real time.
Reltio for Life Sciences velocity pack enables companies to manage their customer data with HCOs (healthcare organizations), and HCPs (healthcare professionals) to improve engagement, sales and marketing effectiveness, improve efficiency, and accelerate growth.
These velocity packs for Life Sciences and Healthcare have pre-built data ingestion from various third-party sources and applications to unify and enrich data.

Quarter of Healthcare Ransomware Victims Forced to Halt Operations

Retrieved on:

Tuesday, October 11, 2022

Organization, Trend Micro, AWS, News, TYO, Intelligence, TSE, NDR, EDR, Risk, Research, HCO, Microsoft, Compliance, XDR, Medical device, Vaccine, Google

DALLAS, Oct. 11, 2022 /PRNewswire/ -- Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today revealed that 86% of global healthcare organizations (HCOs) that have been compromised by ransomware suffered operational outages.

Key Points:

Trend Micro research reveals 86% of global healthcare organizations compromised by ransomware suffered outages.
Most (57%) global HCOs admit being compromised by ransomware over the past three years, according to the study.
Of these, 25% say they were forced to completely halt operations, while 60% reveal that some business processes were impacted as a result.
But in the healthcare sector, ransomware can have a potentially very real and very dangerous physical impact," said Bharat Mistry, Technical Director at Trend Micro.

SolarWinds to Showcase Hybrid Cloud Observability Platform at GITEX GLOBAL 2022

Retrieved on:

Tuesday, October 11, 2022

SolarWinds Hybrid Cloud Observability provides end-to-end oversight, helping teams be more informed, efficient, and agile.

Key Points:

SolarWinds Hybrid Cloud Observability provides end-to-end oversight, helping teams be more informed, efficient, and agile.
GITEX GLOBAL 2022 is an exciting opportunity to showcase how SolarWinds and our value-added distribution Partners in the region can help organizations drive forward IT modernization and cloud migration initiatives, said Abdul Rehman Tariq, Regional Sales Director, Middle East.
SolarWinds Hybrid Cloud Observability is a comprehensive, integrated, and full-stack observability solution designed to integrate data from across the IT ecosystem, including networks, servers, applications, databases, and more.
Join SolarWinds engineers and product experts for live product demonstrations of Hybrid Cloud Observability (HCO) , database management , IT service management (ITSM) , and IT operations management solutions (ITOM) at Booth #H7-F30.